Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07823894

Boomerang-Shaped Cartilage Graft in Endoscopic Tympanoplasty

This study evaluates the anatomical and functional outcomes of using a boomerang-shaped chondroperichondrial graft in endoscopic Type I tympanoplasty for repairing anterior or subtotal tympanic membrane perforations.

Anterior and subtotal eardrum perforations represent challenging surgical scenarios due to limited visualization, lack of anterior graft support, and higher risks of graft retraction, medialization, or residual perforation. The boomerang-shaped cartilage and perichondrium graft provides a sturdy cartilage framework along the anterior border to secure structural support, while maintaining a thin perichondrial layer over the functional vibratory area to facilitate acoustic transmission.

All enrolled participants undergo endoscopic Type I tympanoplasty using this autologous grafting technique. Follow-up assessments are conducted at 1, 3, and 6 months after surgery to determine successful graft uptake, evaluate hearing improvement (via pure-tone audiometry and air-bone gap closure), and monitor for complications such as blunting, retraction, lateralization, or infection.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Anterior or subtotal tympanic membrane perforation
  • Dry ear for at least 3 months prior to surgery
  • Intact and mobile ossicular chain on clinical and intraoperative assessment
  • Aerated middle ear with healthy or near-normal middle ear mucosa
  • No evidence of cholesteatoma
  • Ability to attend all scheduled postoperative follow-up visits
  • Provision of written informed consent

Exclusion criteria

  • Active ear discharge at the time of surgery
  • Presence of cholesteatoma
  • Marginal or attic perforation associated with pathology requiring mastoid surgery
  • Ossicular discontinuity or erosion requiring ossiculoplasty
  • Significant adhesive otitis media
  • Previous failed tympanoplasty in the same ear
  • Severe Eustachian tube dysfunction associated with adhesive disease
  • Craniofacial anomalies affecting the ear
  • Uncontrolled systemic disease contraindicating surgery
  • Narrow external auditory canal precluding endoscopic access
  • Inability to complete the planned follow-up period

Treatment and study plan

Endoscopic Type I Tympanoplasty with Boomerang-Shaped Chondroperichondrial Graft

Procedure

Endoscopic Type I tympanoplasty performed using a rigid endoscope to repair anterior or subtotal tympanic membrane perforations. The autologous boomerang-shaped chondroperichondrial graft provides a stable anterior cartilage framework to prevent graft medialization, retraction, and residual perforation, while preserving a thin perichondrial layer over the functional vibratory surface to optimize acoustic transfer. Anatomical graft uptake and complication rates are monitored at 1, 3, and 6 months postoperatively, and functional hearing outcomes (pure-tone audiometry thresholds and air-bone gap closure) are measured at 6 months.

Primary outcomes

  1. Graft Uptake Rate

    Time frame: 6 months postoperatively

    Percentage of patients achieving complete anatomical closure and intact healing of the tympanic membrane perforation without residual defect, verified by postoperative otoscopic and endoscopic examination.

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Boomerang-Shaped Cartilage/Perichondrial Graft in Endoscopic Tympanoplasty for Anterior or Subtotal Tympanic Membrane Perforations

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.